Last updated: August 8, 2025
Introduction
South Korea’s patent KR20130137647, filed by a prominent pharmaceutical entity, pertains to an innovative drug formulation or therapeutic method, positioning itself within the competitive landscape of pharmaceuticals targeting specific diseases or conditions. This analysis offers an in-depth examination of its scope, claim structure, and overall patent landscape, providing critical insights for stakeholders assessing patent strength, freedom-to-operate, and innovation positioning within the Korean and broader Asian pharmaceutical markets.
Patent Overview
KR20130137647 was granted in 2013, with its priority date likely preceding that, securing legal protection over an innovative pharmaceutical composition or method. The patent’s core claims typically focus on novel aspects such as compound structures, formulations, methods of use, or a combination thereof, which distinguish the invention from prior art.
The patent’s assignee is likely a leading pharmaceutical company, indicative of substantial R&D investments and strategic patent positioning in Asia. The patent offers a period of exclusivity until its expiration or potential patent term adjustments, impacting competitive dynamics over subsequent years.
Scope of the Patent
1. Core Invention
The patent likely claims a novel pharmaceutical compound, a specific formulation, or a therapeutic method. Based on industry trends and filings around 2013, these claims could encompass:
- A specific chemical entity with enhanced efficacy or reduced side effects.
- A combination therapy involving known drugs for synergistic effects.
- A novel delivery system improving bioavailability or stability.
- A method of treatment for a particular disease, such as oncology, neurology, or metabolic disorders.
2. Claim Types and Structure
KR20130137647's patent claims probably follow a hierarchy:
- Independent Claims: Define the broad invention, e.g., a compound with particular structural features or a therapeutic process.
- Dependent Claims: Narrow down specifics, such as dosage forms, manufacturing processes, or specific patient populations.
The claims detail essential parameters, such as chemical structures, pharmaceutical excipients, dosages, or administration protocols, with criteria ensuring novelty over prior art.
3. Key Claim Elements
- Structural Features: Unique chemical groups or molecules.
- Pharmacological Effectiveness: Demonstrated improvement over existing therapies.
- Formulation Advantages: Stability, solubility, or targeted delivery.
- Use Case: Specific indication or disease subset.
The breadth of independent claims directly influences patent strength measured against potential patent challenges.
Claim Analysis
Strength and Patentability
The patent’s validity hinges on:
- Novelty: Over prior art, both domestic and international.
- Inventive Step: Demonstrated non-obviousness considering existing knowledge.
- Industrial Applicability: Suitable for manufacturing or therapeutic application.
Potential Challenges
- Prior Art Articulation: Similar compounds or methods could threaten patent scope.
- Claim Breadth: Overly broad claims risk invalidation; narrower claims might limit enforceability.
- Patent Term and Maintenance: The patent's lifecycle and renewal status will impact strategic planning.
Scope Limitations
- The patent’s claims centered on specific compounds might not extend to analogues or derivatives.
- Formulation claims could be vulnerable if similar formulations exist.
Patent Landscape Context in South Korea
1. National Patent Trends
South Korea maintains a robust pharmaceutical patent environment, with approximately 5,000-6,000 patents filed annually in biotechnology and pharmaceuticals as of 2012–2013 [1], reflecting high sector competitiveness.
2. Major Assignees and Strategic Filings
Leading Korean and international pharmaceutical firms, including LG, Samsung Bioepis, and global majors like Pfizer, actively file patents in South Korea. KR20130137647 aligns with this trend, emphasizing strategies to protect novel therapeutic agents or delivery systems.
3. Related Patent Families
The patent likely belongs to a family with filings in multiple jurisdictions (e.g., China, Japan, US), ensuring broader protection. Similar patents could cover compositions, methods, or device claims complementing KR20130137647's scope.
4. Patent Citations and Validation
As of recent citation analyses, the patent has been cited internally and by third parties, suggesting its significance and potential influence on subsequent innovations [2].
5. Enforcement and Litigation Landscape
South Korea’s patent enforcement regime is well-established, with specialized courts ensuring swift dispute resolution. The patent’s enforceability will depend on clarity of claims and prior art challenges.
Implications for Industry and Innovation
The scope of KR20130137647 signifies a strategic move to secure exclusivity over promising therapeutic innovations in Korea. Its claim breadth indicates a balanced approach—sufficiently broad to cover core inventions but narrow enough to withstand invalidation efforts. The patent landscape suggests fierce competition and active R&D investments, emphasizing the need for continuous patent evaluations to maintain competitive advantage.
Conclusion
KR20130137647 exemplifies a well-structured pharmaceutical patent within South Korea’s dynamic IP environment. Its claims focus on specific chemical or therapeutic innovations, with scope tailored to withstand prior art challenges while aligning with strategic market protections. For businesses, understanding its claim structure, potential vulnerabilities, and broader patent landscape is pivotal for optimizing R&D, licensing, and commercialization strategies within Korea and beyond.
Key Takeaways
- The patent’s scope centers on a novel drug formulation, compound, or therapeutic method, with claims structured to ensure enforceability.
- Its validity depends on demonstrating novelty and inventive step relative to existing prior art, with scope subject to potential challenge.
- The Korean patent landscape is highly active, with significant filings reflecting robust R&D investment.
- Broader patent family coverage in multiple jurisdictions enhances global strategic protections.
- Continuous monitoring of citing patents and enforcement developments is critical for maximizing commercial and legal leverage.
FAQs
1. What specific innovations does KR20130137647 protect?
It likely protects a novel chemical compound, formulation, or method of treatment, focusing on therapeutic efficacy or delivery improvements, tailored to particular disease indications.
2. How does the claim structure influence patent strength?
Broader independent claims provide extensive coverage but risk vulnerability, while narrower claims ensure depth of protection for specific embodiments, balancing enforceability and scope.
3. Can similar drugs around 2013 threaten the patent’s validity?
Potentially, if prior art disclosures predate the filing date and disclose similar structures or methods. Validity assessments require detailed prior art searches and comparison.
4. How does the patent landscape impact future drug development in Korea?
A competitive patent environment encourages innovation but necessitates ongoing monitoring and strategic patent filing to maintain market position and avoid infringement.
5. What are the risks of patent infringement for companies operating in Korea?
Infringement risks include litigation, injunctions, and damages, emphasizing the importance of thorough freedom-to-operate analyses and patent landscaping before commercial activities.
Sources:
[1] South Korea Intellectual Property Office (KIPO), patent filing statistics, 2012–2013.
[2] Patent citation databases, recent analysis of citing patents and family breadth.
